Valentina Volynets1, Astrid Reichold1, Gyöngyi Bárdos1, Andreas Rings1, André Bleich2, Stephan C Bischoff3. 1. Department of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70593, Stuttgart, Germany. 2. Institute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany. 3. Department of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70593, Stuttgart, Germany. bischoff.stephan@uni-hohenheim.de.
Abstract
BACKGROUND: Intestinal permeability is thought to be of major relevance for digestive and nutrition-related diseases, and therefore has been studied in numerous mouse models of disease. However, it is unclear which tools are the preferable ones, and how normal values should be defined. AIMS: To compare different in vivo permeability tests in healthy mice of commonly used genetic backgrounds. METHODS: We assessed the intestinal barrier in male and female C57BL/6J and BALB/cJ mice of different ages, using four orally administered permeability markers, FITC-dextran 4000 (FITC-D4000) and ovalbumin (OVA) measured in plasma, and polyethylene glycol (PEG) and lactulose/mannitol (Lac/Man) measured in urine, and by assessing lipopolysaccharide (LPS) in portal vein plasma. RESULTS: After gavage, FITC-D4000, OVA, Lac/Man, and PEG400, but not PEG4000, were detectable in plasma or urine. Female mice tended to have a higher permeability according to the FITC-D4000, OVA, and PEG400 tests, but the Lac/Man ratio was higher in males. No significant differences between the two mouse strains of young and old mice were observed except for mannitol recovery, which was higher in BALB/cJ mice compared to C57BL/6J mice (p < 0.05). Virtually no LPS was detected in healthy mice. For all markers, normal values have been defined based on 5th-95th percentile ranges of our data. CONCLUSION: Selected oral permeability tests, such as FITC-D4000, OVA, PEG400, and Lac/Man, as well as LPS measurements in portal vein plasma, could be suitable for the evaluation of the intestinal barrier in mice, if used in a standardized way.
BACKGROUND: Intestinal permeability is thought to be of major relevance for digestive and nutrition-related diseases, and therefore has been studied in numerous mouse models of disease. However, it is unclear which tools are the preferable ones, and how normal values should be defined. AIMS: To compare different in vivo permeability tests in healthy mice of commonly used genetic backgrounds. METHODS: We assessed the intestinal barrier in male and female C57BL/6J and BALB/cJ mice of different ages, using four orally administered permeability markers, FITC-dextran 4000 (FITC-D4000) and ovalbumin (OVA) measured in plasma, and polyethylene glycol (PEG) and lactulose/mannitol (Lac/Man) measured in urine, and by assessing lipopolysaccharide (LPS) in portal vein plasma. RESULTS: After gavage, FITC-D4000, OVA, Lac/Man, and PEG400, but not PEG4000, were detectable in plasma or urine. Female mice tended to have a higher permeability according to the FITC-D4000, OVA, and PEG400 tests, but the Lac/Man ratio was higher in males. No significant differences between the two mouse strains of young and old mice were observed except for mannitol recovery, which was higher in BALB/cJ mice compared to C57BL/6J mice (p < 0.05). Virtually no LPS was detected in healthy mice. For all markers, normal values have been defined based on 5th-95th percentile ranges of our data. CONCLUSION: Selected oral permeability tests, such as FITC-D4000, OVA, PEG400, and Lac/Man, as well as LPS measurements in portal vein plasma, could be suitable for the evaluation of the intestinal barrier in mice, if used in a standardized way.
Authors: M Camilleri; K Madsen; R Spiller; B Greenwood-Van Meerveld; B G Van Meerveld; G N Verne Journal: Neurogastroenterol Motil Date: 2012-06 Impact factor: 3.598
Authors: Stephan C Bischoff; Giovanni Barbara; Wim Buurman; Theo Ockhuizen; Jörg-Dieter Schulzke; Matteo Serino; Herbert Tilg; Alastair Watson; Jerry M Wells Journal: BMC Gastroenterol Date: 2014-11-18 Impact factor: 3.067
Authors: Kim van Wijck; Babs Afm Bessems; Hans Mh van Eijk; Wim A Buurman; Cornelis Hc Dejong; Kaatje Lenaerts Journal: Clin Exp Gastroenterol Date: 2012-07-19
Authors: Valentina Volynets; Andreas Rings; Gyöngyi Bárdos; Maureen J Ostaff; Jan Wehkamp; Stephan C Bischoff Journal: Tissue Barriers Date: 2016-07-08
Authors: Paula Marincola Smith; Yash A Choksi; Nicholas O Markham; David N Hanna; Jinghuan Zi; Connie J Weaver; Jalal A Hamaamen; Keeli B Lewis; Jing Yang; Qi Liu; Izumi Kaji; Anna L Means; R Daniel Beauchamp Journal: Am J Physiol Gastrointest Liver Physiol Date: 2021-03-24 Impact factor: 4.052
Authors: Pablo Giménez-Gómez; Mercedes Pérez-Hernández; Esther O'Shea; Javier R Caso; David Martín-Hernandez; Luis Alou Cervera; María Luisa Gómez-Lus Centelles; María Dolores Gutiérrez-Lopez; Maria Isabel Colado Journal: FASEB J Date: 2019-09-11 Impact factor: 5.191
Authors: Kathryn A Knoop; Devesha H Kulkarni; Keely G McDonald; Jenny K Gustafsson; Jazmyne E Davis; Alexandria N Floyd; Rodney D Newberry Journal: Lab Anim (NY) Date: 2020-02-10 Impact factor: 12.625
Authors: Laura E Ewing; Charles M Skinner; Rupak Pathak; Eric U Yee; Kim Krager; Patrick C Gurley; Stepan Melnyk; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash Journal: Int J Radiat Oncol Biol Phys Date: 2020-09-28 Impact factor: 7.038